Canada Main Menu for Taxonomy

What is Omnipod®?
Is Omnipod® Right for Me?
Current Podders®
Diabetes Hub

Select Region

United States
Estados Unidos - Español
Australia
België - Nederlands
Belgique - Français
Canada - English
Canada - Français
Croatia - English
Danmark - Dansk
Denmark - English
Deutschland
Finland - English
Suomi - Suomalainen
France
Greece - English
Iceland - English
Italia
Israel - English
Kuwait - English
Nederland
Norge - Norsk
Norway - English
Österreich
Qatar - English
Saudi Arabia - English
Schweiz - Deutsch
Suisse - Français
Svizzero - Italiano
Sverige - Svenska
Sweden - English
Turkey - English
United Arab Emirates - English
United Kingdom
Other

Secondary Menu for Taxonomy

Healthcare Providers
Contact Us
Login
Login
Login

Learning Center

Diabetes Technology

Diabetes technology has developed recently. Here, you can learn more on how to manage your diabetes with technology, what the current options are, how the technology works and future developments in diabetes technology. These modules aim to help build up your knowledge and understand what might be the best option for you.

There are no related articles yet.

Canada Social Media Menu

©2018-2025 Insulet Corporation. Omnipod, the Omnipod logos, DASH, the DASH logo, the Omnipod 5 logo, SmartAdjust, Omnipod DISPLAY, Omnipod VIEW, Omnipod DEMO, Podder, Simplify Life, Toby the Turtle, PodderCentral, the PodderCentral logo, Podder Talk, PodPals, Pod University, and OmnipodPromise are trademarks or registered trademarks of Insulet Corporation. All rights reserved. Glooko is a trademark of Glooko, Inc. and used with permission. Dexcom and Dexcom G6 and G7 are registered trademarks of Dexcom, Inc. and used with permission. The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission. The Bluetooth® word mark and logos are registered trademarks owned by the Bluetooth SIG, Inc., and any use of such marks by Insulet Corporation is under license. All other trademarks are the property of their respective owners. The use of third-party trademarks does not constitute an endorsement or imply a relationship or other affiliation.

Intended Purpose as per Instructions for Use for The Omnipod 5 Automated Insulin Delivery System:

The Omnipod 5 Automated Insulin Delivery System is a single hormone insulin delivery system intended to deliver U-100 insulin subcutaneously for the management of type 1 diabetes in persons aged 2 and older requiring insulin. The Omnipod 5 System is intended to operate as an automated insulin delivery system when used with compatible Continuous Glucose Monitors (CGM). When in Automated Mode, the Omnipod 5 System is designed to assist people with type 1 diabetes in achieving glycaemic targets set by their healthcare providers. It is intended to modulate (increase, decrease or suspend) insulin delivery to operate within predefined threshold values using current and predicted sensor glucose values to maintain blood glucose at variable target glucose levels, thereby reducing glucose variability. This reduction in variability is intended to lead to a reduction in the frequency, severity, and duration of both hyperglycaemia and hypoglycaemia. The Omnipod 5 System can also operate in a Manual Mode that delivers insulin at set or manually adjusted rates. The Omnipod 5 System is intended for single patient use. The Omnipod 5 System is indicated for use with U-100 rapid acting insulin.

Warning: DO NOT start to use the Omnipod® 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over delivery or under-delivery of insulin, which could lead to hypoglycaemia or hyperglycaemia.

Intended Purpose as per Instructions for Use for The Omnipod DASH® Insulin Management System:

The Omnipod DASH® Insulin Management System is intended for subcutaneous delivery of insulin at set and variable rates for the management of diabetes mellitus in persons requiring insulin. The Omnipod DASH® System is indicated for use with U-100 rapid acting insulin.

Warning: Do NOT attempt to use the Omnipod DASH System before you receive training. Inadequate training could put your health and safety at risk.

Diabetes Technology

Other topics